MoneyWorks4Me

Zim Laboratories - Quaterly Results

03 Aug 2024 Evaluate
The Revenue for the quarter ended  June 2024 of Rs. 820.04 millions grew by 22.38 % from Rs. 670.07 millions.The Total Profit for the quarter ended June 2024 of Rs. 7.59 millions grew from Rs.-1.42 millionsThe company reported a good operating profit of 88.58 millions compared to 51.72 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 820.04 670.07 22.38 820.04 670.07 22.38 3654.73 3965.31 -7.83
Other Income 9.80 6.32 55.06 9.80 6.32 55.06 46.91 64.31 -27.06
PBIDT 88.58 51.72 71.27 88.58 51.72 71.27 447.94 576.21 -22.26
Interest 28.58 17.34 64.82 28.58 17.34 64.82 69.24 55.75 24.20
PBDT 60.00 34.38 74.52 60.00 34.38 74.52 378.70 520.46 -27.24
Depreciation 49.16 36.60 34.32 49.16 36.60 34.32 148.29 161.28 -8.05
PBT 10.84 -2.22 -588.29 10.84 -2.22 -588.29 230.41 359.18 -35.85
TAX 3.25 -0.80 -506.25 3.25 -0.80 -506.25 62.84 109.09 -42.40
Deferred Tax 1.15 -0.80 -243.75 1.15 -0.80 -243.75 54.55 46.30 17.82
PAT 7.59 -1.42 -634.51 7.59 -1.42 -634.51 167.57 250.09 -33.00
Equity 487.26 487.26 0.00 487.26 487.26 0.00 487.26 487.26 0.00
PBIDTM(%) 10.80 7.72 39.95 10.80 7.72 39.95 12.26 14.53 -15.66
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..